| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;47:545.)
© 2006 American Heart Association, Inc.
Part 2 Original Articles |
From the Center for Clinical Pharmacology, Departments of Medicine (Z.M., C.Z., L.G., E.K.J.) and Pharmacology (J.H.D., E.K.J.), University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Correspondence to Edwin K. Jackson, Center for Clinical Pharmacology, University of Pittsburgh School of Medicine, 100 Technology Dr, Suite 450, Pittsburgh, PA 15219. E-mail edj{at}pitt.edu
The Gi pathway augments renal vasoconstriction induced by angiotensin II in spontaneously hypertensive but not normotensive Wistar-Kyoto rats. Because the Gi-coupled pancreatic polypeptide (PP)-fold peptide receptors Y1 and Y2 are expressed in kidneys and are activated by endogenous PP-fold peptides, we tested the hypothesis that these receptors regulate angiotensin II-induced renal vasoconstriction in kidneys from hypertensive but not normotensive rats. A selective Y1-receptor agonist [(Leu31,Pro34)-neuropeptide Y; 6 to 10 nmol/L] greatly potentiated angiotensin IIinduced changes in perfusion pressure in isolated, perfused kidneys from hypertensive but not normotensive rats. A selective Y2-receptor agonist (peptide YY3-36; 6 nM) only slightly potentiated angiotensin IIinduced renal vasoconstriction and only in kidneys from hypertensive rats. Neither the Y1-receptor nor the Y2-receptor agonist increased basal perfusion pressure. BIBP3226 (1 µmol/L, highly selective Y1-receptor antagonist) and BIIE0246 (1 µmol/L, highly selective Y2-receptor antagonist) completely abolished potentiation by (Leu31,Pro34)-neuropeptide Y and peptide YY3-36, respectively. Y1-receptor and Y2-receptor mRNA and protein levels were expressed in renal microvessels and whole kidneys, but the abundance was similar in kidneys from hypertensive and normotensive rats. Both Y1-receptorinduced and Y2-receptorinduced potentiation of angiotensin IImediated renal vasoconstriction was completely abolished by pretreatment with pertussis toxin (30 µg/kg IV, blocks Gi proteins). These data indicate that, in kidneys from genetically hypertensive but not normotensive rats, Y1-receptor activation markedly enhances angiotensin IImediated renal vasoconstriction by a mechanism involving Gi. Although Y2 receptors can also potentiate angiotensin IImediated renal vasoconstriction via Gi, the effect is modest compared with Y1 receptors. These findings may have important implications for the etiology of genetic hypertension.
Key Words: receptors neuropeptides peptides hypertension
This article has been cited by other articles:
![]() |
E. K. Jackson and Z. Mi Sitagliptin Augments Sympathetic Enhancement of the Renovascular Effects of Angiotensin II in Genetic Hypertension Hypertension, June 1, 2008; 51(6): 1637 - 1642. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson, M. Zhang, W. Liu, and Z. Mi Inhibition of Renal Dipeptidyl Peptidase IV Enhances Peptide YY1 36-Induced Potentiation of Angiotensin II-Mediated Renal Vasoconstriction in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 431 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Dubinion, Z. Mi, and E. K. Jackson Role of Renal Sympathetic Nerves in Regulating Renovascular Responses to Angiotensin II in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1330 - 1336. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |